Diabetes Medications and Cardiovascular Disease Prevention

Prevention Conference VI : Diabetes and Cardiovascular Disease

The American Heart Association (AHA) sponsored a scientific conference entitled “Prevention VI: Diabetes and Cardiovascular Disease” on January 18 to 20, 2001, in Orlando, Fla. The purpose of this conference was to create a report that would assist the AHA in the development of an agenda to reduce cardiovascular diseases (CVDs) that are associated with diabetes. The report has been developed by...

Cardiovascular disease prevention in diabetes: uncertainties and ethics

Implementing a State-Based Cardiovascular Disease and Diabetes Prevention Program

OBJECTIVE To evaluate weight loss and cardiometabolic risk reduction achieved through an adapted Diabetes Prevention Program intervention among adults at high risk for cardiovascular disease (CVD) and diabetes. RESEARCH DESIGN AND METHODS Eight health care facilities implemented a group-based lifestyle intervention beginning in 2008. Participants attended 16 weekly core sessions followed by 6...

Diabetes and Cardiovascular Disease Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes Reconciling the Recent Clinical Trial Data

Cardiovascular disease (CVD) is a very common, if not the most common, cause of morbidity and mortality in developed countries, and there has been longstanding recognition that diabetes is a potent risk factor for CVD.1–3 Individuals with either type 1 or type 2 diabetes mellitus manifest CVD rates up to 4 to 10 times higher than those observed in nondiabetic subjects. Subjects with diabetes al...

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.

Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D meet recommended guidelines for CVD prevention. The burden of T2D is increasing: by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with T2D will comprise an increasingly large proportion of the CVD population. Th...